Mouse stem cell study offers new insights into body fat distribution
Visceral fat – the so-called "pot-belly" – indicates a much higher risk of cardiovascular disease and type 2 diabetes than subcutaneous fat. This discovery will help us to understand the fundamental biology underpinning these two major causes of obesity-related morbidity and mortality in the developed world. During development, some groups of stem cells will go on to become adipose cells – the large globular cells that store and metabolise fats from our diets.
This research suggests that the distribution of visceral versus subcutaneous adipose cells is at least in part down to the nutrition available to stem cells during the early stages of development. The study, led by Professor Kevin Docherty of the University of Aberdeen, found that adding palmitate (a major component in palm oil) to mouse stem cells affected how they responded to androgen and oestrogen - the sex hormones which normally control the types of fat cells that stem cells become.
Professor Docherty said "This finding is an important insight as it suggests that nutrition in early development can affect how and where fat is stored in later life. We've known for a while that having a pot-belly suggests someone's risk of developing type 2 diabetes and heart disease is high, but there is still a lot to learn about why body fat distribution varies so much between people. Our research helps by putting another small piece into the puzzle. "Type 2 diabetes used to be a disease that struck people in later life, but in the UK and some other developed countries we're seeing a worrying increase of this problem amongst overweight teenagers and younger adults. In the UK, 30% of teenagers are overweight or obese so it's crucial that we understand the fundamental biology of weight-related diseases so that we can develop better ways of preventing, treating and managing this serious problem."
The researchers hope that this study might lead to new insights into how to combat type 2 diabetes and cardiovascular disease. Professor Docherty concluded: "The number one way of reducing the number of overweight people is improving diet and encouraging exercise, but we hope our research might eventually offer insights that lead to new treatments including drugs to reduce these high-risk fat stores around organs."
Most read news
Topics
Organizations
Other news from the department science
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.